BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Tyrosine-protein kinase BTK [393-659]' and Ligand = 'BDBM287215'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Tyrosine-protein kinase BTK [393-659]


(Homo sapiens (Human))
BDBM287215
PNG
(US9567339, Example A.4.11)
Show SMILES Cc1c(NC2COC2)cccc1-c1ccc(C(N)=O)c2[nH]c(cc12)C1=CCN(CC1)S(C)(=O)=O |t:28|
Show InChI InChI=1S/C25H28N4O4S/c1-15-18(4-3-5-22(15)27-17-13-33-14-17)19-6-7-20(25(26)30)24-21(19)12-23(28-24)16-8-10-29(11-9-16)34(2,31)32/h3-8,12,17,27-28H,9-11,13-14H2,1-2H3,(H2,26,30)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a<100n/an/an/an/a6.525



AbbVie Inc.

US Patent


Assay Description
The in-house BTK corresponds to recombinant human catalytic domain (aa 393-659), which was expressed in SF9 cells with an N-terminal his tag and puri...


US Patent US9567339 (2017)


BindingDB Entry DOI: 10.7270/Q2P2715T
More data for this
Ligand-Target Pair